Report
Chris Kallos, CFA
EUR 101.80 For Business Accounts Only

Monash Trading Update Highlights Impact of One-Off Costs and Focus on Premium Service Offering

We reduce our fair value estimate for no-moat-rated Monash IVF Group to AUD 1.60 from AUD 1.80, following guidance provided at the annual general meeting that flagged first-half 2018 net profit after tax of around AUD 12 million, or 20% lower than the previous corresponding period. This was due to a combination of one-off expenses related to legal costs and CEO recruitment, amounting to around AUD 600,000 pretax, and a 6.6% decline on the prior corresponding period in Monash fresh IVF volumes fo...
Underlying
Monash IVF Group

Healthbridge Enterprises is engaged in the provision of medical services in the area of human reproduction and human pathology.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Chris Kallos, CFA

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch